Parkinson's Disease Prognosis

Parkinson’s disease is not a fatal illness. However, it’s a degenerative disorder that usually progresses until it leaves its patients completely debilitated. The condition usually worsens over an average of 15 years.

The rate of progression and its course varies among patients. The course is relatively benign in some patients with little disability after twenty years and may be more aggressive among others who may be severely disabled after ten years. Those with an early onset Parkinson’s disease have shorter life spans than those with later-onset disease.

Untreated prognosis

Untreated, Parkinson’s disease worsens over years. Parkinson's may lead to a deterioration of all brain functions and an early death. Life expectancy however is normal to near normal in most treated patients of Parkinson’s disease.

Prognosis with medications

Most people respond to medications. However, the extent of responsiveness and the duration of how long the efficacy of the drug lasts varies from person to person. The side effects of medications are another deterrent in their use.

Movement disorder symptoms differ from person to person. For some they are more bothersome than others depending on what a person normally does during the day. In some the mild symptoms may last for many years while in others they may develop more quickly. Non-motor symptoms may also vary from person to person. They affect most people with Parkinson's at all stages of disease.  Some people with Parkinson's find that symptoms such as depression or fatigue may be more cumbersome to deal with that the movement disorders themselves.

Complications of Parkinson’s

Complications associated with Parkinson’s disease usually lead to a lowered life expectancy rather than the disease itself. PD may cause complications such as choking, pneumonia, and falls leading to severe injury or death.

Stages of Parkinson’s

There are several rating scales that may be used as tools to understand the progression of the disease. The stages of Parkinson's correspond to severity of movement symptoms and to the degree of impairment in a person’s daily activities.

The most commonly used rating scales are focused on the motor symptoms. Commonly used scales are:-

  • Hoehn and Yahr scale that rate symptoms on a scale of 1 to 5.  On this scale, depending on a person’s difficulties, 1 and 2 represent early-stage, 2 and 3 mid-stage, and 4 and 5 advanced-stage Parkinson's.
  • United Parkinson’s Disease Rating Scale (UPDRS) scale is more comprehensive than the Hoehn and Yahr scale. It takes into account cognitive difficulties, ability to carry out daily activities, behaviour, mood, and treatment complications along with movement symptoms.

Further Reading

Last Updated: Jul 4, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 04). Parkinson's Disease Prognosis. News-Medical. Retrieved on July 13, 2024 from

  • MLA

    Mandal, Ananya. "Parkinson's Disease Prognosis". News-Medical. 13 July 2024. <>.

  • Chicago

    Mandal, Ananya. "Parkinson's Disease Prognosis". News-Medical. (accessed July 13, 2024).

  • Harvard

    Mandal, Ananya. 2023. Parkinson's Disease Prognosis. News-Medical, viewed 13 July 2024,


  1. Marlene Isabel Dominguez Marlene Isabel Dominguez Peru says:

    qiero saber sy el temblor en un ojo es sintoma de parkinson,mi madre tuvo la enfermedad.yo tengo 47 años

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Chronic caffeine intake may impact brain chemistry in Parkinson's disease